These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 163843)

  • 21. Extra-thyroidal origin of the heaviest fractions of circulating human "calcitonin".
    Argémi B
    Calcif Tissue Res; 1976 Aug; 21 Suppl():310-6. PubMed ID: 953819
    [No Abstract]   [Full Text] [Related]  

  • 22. Radioimmunoassay of urinary calcitonin in normal subjects and in patients with medullary carcinoma of the thyroid.
    Morimoto S; Onishi T; Okada Y; Lee S; Imanaka S; Fukuo K; Kono H; Kumahara Y
    Endocrinol Jpn; 1982 Feb; 29(1):1-10. PubMed ID: 7106058
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The ectopic secretion of calcitonin by lung and breast carcinomas.
    Coombes RC; Ellison ML; Easty GC; Hillyard CJ; James R; Galante L; Girgis S; Heywood L; MacIntyre I; Neville AM
    Clin Endocrinol (Oxf); 1976; 5 Suppl():387S-396S. PubMed ID: 1053252
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Release of calcitonin by cultures of medullary carcinoma of the thyroid.
    Lichtenberger LM; Singer FR
    Endocr Res Commun; 1975; 2(8):527-36. PubMed ID: 1222721
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pancreatic islet cell carcinoma producing gastrin, ACTH, alpha-endorphin, somatostatin and calcitonin.
    Asa SL; Kovacs K; Killinger DW; Marcon N; Platts M
    Am J Gastroenterol; 1980 Jul; 74(1):30-5. PubMed ID: 6107042
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Malignant islet cell tumor of the pancreas associated with high plasma calcitonin and somatostatin levels.
    Howard JM; Gohara AF; Cardwell RJ
    Surgery; 1989 Feb; 105(2 Pt 1):227-9. PubMed ID: 2563598
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunochemical heterogeneity of calcitonin in renal failure.
    Lee JC; Parthemore JG; Deftos LJ
    J Clin Endocrinol Metab; 1977 Sep; 45(3):528-33. PubMed ID: 903401
    [No Abstract]   [Full Text] [Related]  

  • 28. Calcium infusion and pentagastrin injection in diagnosis of medullary thyroid carcinoma.
    Verdy M; Cholette JP; Cantin J; Lacroix A; Sturtridge WC
    Can Med Assoc J; 1978 Jul; 119(1):29-35. PubMed ID: 679097
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The differential diagnosis of hypercalcitoninism].
    Dambacher MA; Born W; Heitz PU; Olah AJ; Tobler PH; Fischer JA
    Schweiz Med Wochenschr; 1981 Dec; 111(49):1897-901. PubMed ID: 7330642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Radioimmunoassay of plasma calcitonin gene-related peptide (CGRP) levels in patients with endocrine tumor].
    Takami H; Shikata J; Horie H; Horiuchi J; Sakurai H; Ito K
    Gan To Kagaku Ryoho; 1989 Jun; 16(6):2219-25. PubMed ID: 2786708
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor and plasma somatostatin-like immunoreactivity in transplantable rat medullary thyroid carcinoma.
    Birnbaum RS; Muszynski M; Roos BA
    Cancer Res; 1980 Nov; 40(11):4192-6. PubMed ID: 6110476
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The determination of human calcitonin by an radioimmunological method].
    Moukhtar MS
    Biomed Pharmacother; 1984; 38(5):257-60. PubMed ID: 6525422
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Calcitonin in plasma and cerebrospinal fluid from normal subjects and patients with medullary thyroid carcinoma: possible restriction of calcitonin by the blood-brain barrier.
    Morimoto S; Nishimura J; Miyauchi A; Takai S; Okada Y; Onishi T; Fukuo K; Lee S; Kumahara Y
    J Clin Endocrinol Metab; 1982 Sep; 55(3):594-6. PubMed ID: 7096542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improvement of the calcitonin radioimmunoassay.
    Wood WG; Müller OA; Stalla G; Scriba PC
    J Clin Chem Clin Biochem; 1979 Dec; 17(12):781-7. PubMed ID: 547038
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Calcitonin as a tumor marker. Use of the radioimmunoassay for calcitonin in the postoperative evaluation of patients with medullary thyroid carcinoma.
    Goltzman D; Potts JT; Ridgway RC; Maloof F
    N Engl J Med; 1974 May; 290(19):1035-9. PubMed ID: 4207025
    [No Abstract]   [Full Text] [Related]  

  • 36. "Nonspecific" increases in plasma immunoreactive calcitonin in healthy individuals: discrimination from medullary thyroid carcinoma by a new extraction technique.
    Body JJ; Heath H
    Clin Chem; 1984 Apr; 30(4):511-4. PubMed ID: 6323053
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Plasma tumor markers (calcitonin and carcinoembryonic antigen) in medullary thyroid cancers].
    Argémi B; Vagneur JP; Conforto C; Even F; Rollat MC; Simonin R
    Bull Cancer; 1984; 71(2):133-9. PubMed ID: 6733293
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radioimmunoassay for human calcitonin employing synthetic calcitonin M: its clinical application.
    Morita R; Fukunaga M; Yamamoto I; Mori T; Torizuka K
    Endocrinol Jpn; 1975 Oct; 22(5):419-26. PubMed ID: 1061670
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radioimmunoassay of calcitonin in normal human plasma: problems, perspectives and prospects.
    Heath H; Body JJ; Fox J
    Biomed Pharmacother; 1984; 38(5):241-5. PubMed ID: 6525418
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunoreactive calcitonin in medullary carcinoma of the thyroid and in maternal and cord serum.
    Samaan NA; Hill CS; Beceiro JR; Schultz PN
    J Lab Clin Med; 1973 May; 81(5):671-81. PubMed ID: 4735426
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.